col0,col1,col2,col3,col4,col5,col6,col7,col8,col9,col10,col11
R-HSA-212436,Generic Transcription Pathway,20/1107,1082/23216,3.3014423838e-12,3.99474528439e-10,SMARCC2; ZNF214; ZNF169; ZNF133; ZNF3; PPM1A; ZNF337; NR2C2; ZNF354B; KAT5; KAT2A; PRMT5; L3MBTL1; ZNF619; PDPK1; ING5; CCNT2; PIDD1; ZNF696; ZNF770,10419/7761/7551/6601/169841/84289/5494/55367/10524/2648/54989/79943/26013/26152/7182/117608/7692/905/5170/285267,20,2,0.01806684733514,0.046605789110958
R-HSA-3247509,Chromatin modifying enzymes,9/272,270/23216,8.23208157945e-08,1.99216374223e-06,PRDM16; SMARCC2; KAT5; KAT2A; PRMT5; RCOR1; HDAC10; ING5; SETD3,10419/63976/6601/2648/23186/84289/10524/84193/83933,9,2,0.0330882352941176,0.0116299104066161
R-HSA-3700989,Transcriptional Regulation by TP53,7/374,365/23216,9.69032387482e-05,0.00195421531476,PRMT5; KAT5; PIDD1; L3MBTL1; PDPK1; ING5; CCNT2,10419/84289/55367/10524/26013/905/5170,7,2,0.018716577540107,0.0157219159200551
R-HSA-5633007,Regulation of TP53 Activity,5/162,161/23216,0.000116966069812,0.00202184206389,L3MBTL1; PDPK1; ING5; KAT5; PRMT5,10524/10419/26013/5170/84289,5,2,0.0308641975308642,0.0069348725017229
R-HSA-6804760,Regulation of TP53 Activity through Methylation,2/20,19/23216,0.00148081212771,0.0149315222877,L3MBTL1; PRMT5,10419/26013,2,2,0.1,0.0008184011026878
WP138,Androgen receptor signaling pathway,3/89,89/23216,0.00243787741277,0.0194229098575,NR2C2; EFCAB6; KAT5,10524/64800/7182,3,2,0.0337078651685393,0.0038335630599586
myc_pathway,C-MYC pathway,2/25,25/23216,0.00256831865884,0.0194229098575,KAT5; KAT2A,2648/10524,2,2,0.08,0.0010768435561681
WP4204,Tumor suppressor activity of SMARCB1,2/31,31/23216,0.00393559051126,0.0242735425455,SMARCC2; GLI4,2738/6601,2,2,0.0645161290322581,0.0013352860096485
WP4321,Thermogenesis,3/108,108/23216,0.00421276358227,0.0242735425455,SMARCC2; PRDM16; CREB3L4,6601/148327/63976,3,2,0.0277777777777778,0.0046519641626464
R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,2/47,47/23216,0.00887471757708,0.0362331906415,HDAC10; KAT2A,2648/83933,2,2,0.0425531914893617,0.0020244658855961
ar_tf_pathway,Regulation of Androgen receptor activity,2/51,51/23216,0.0103881499075,0.0389651674587,NR2C2; KAT5,7182/10524,2,2,0.0392156862745098,0.002196760854583
p53regulationpathway,p53 pathway,2/58,57/23216,0.0128562514826,0.0398873443436,KAT5; PRMT5,10524/10419,2,2,0.0344827586206897,0.0024552033080634
e2f_pathway,E2F transcription factor network,2/75,73/23216,0.020537316962,0.0507145990287,KAT2A; PRMT5,2648/10419,2,2,0.0266666666666667,0.003144383184011
R-HSA-3214858,RMTs methylate histone arginines,2/74,74/23216,0.0210679160214,0.0509843567718,SMARCC2; PRMT5,6601/10419,2,2,0.027027027027027,0.0031874569262577
WP3656,Interleukin-1 Induced Activation of NF-kappa-B,2/9,9/23216,0.00031776946771,0.00480626319911,UBE2V1; PRKCZ,5590/7335,2,3,0.222222222222222,0.0003876636802205
Pathway_TNFalpha,TNFalpha,5/234,234/23216,0.000659014724202,0.00886008684761,NR2C2; SMARCC2; PRKCZ; PEG3; BTRC,7182/6601/5590/8945/5178,5,3,0.0213675213675214,0.010079255685734
R-HSA-5218921,VEGFR2 mediated cell proliferation,2/19,19/23216,0.00148081212771,0.0149315222877,PDPK1; PRKCZ,5170/5590,2,3,0.105263157894737,0.0008184011026878
gsk3pathway,inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages,2/40,40/23216,0.00648941989904,0.0314087923113,PDPK1; BTRC,5170/8945,2,3,0.05,0.001722949689869
R-HSA-202424,Downstream TCR signaling,2/51,41/23216,0.0068092393454,0.0316891523382,UBE2V1; PDPK1,7335/5170,2,3,0.0392156862745098,0.0017660234321157
hdac_classi_pathway,Signaling events mediated by HDAC Class I,2/56,56/23216,0.0124287149254,0.0395756448942,BTRC; PRMT5,10419/8945,2,3,0.0357142857142857,0.0024121295658166
R-HSA-9020702,Interleukin-1 signaling,2/60,60/23216,0.0141769751572,0.0428853498504,UBE2V1; BTRC,7335/8945,2,3,0.0333333333333333,0.0025844245348035
WP231,TNF alpha Signaling Pathway,2/93,92/23216,0.0315601613786,0.0568612871039,PRKCZ; BTRC,5590/8945,2,3,0.021505376344086,0.0039627842866988
path:hsa05215,Prostate cancer - Homo sapiens (human),2/97,97/23216,0.034774671452,0.0568612871039,PDPK1; CREB3L4,5170/148327,2,3,0.0206185567010309,0.0041781529979324
path:hsa04919,Thyroid hormone signaling pathway - Homo sapiens (human),2/116,116/23216,0.0480696780673,0.0727053880767,PDPK1; KAT2A,5170/2648,2,3,0.0172413793103448,0.0049965541006202
R-HSA-170834,Signaling by TGF-beta Receptor Complex,3/67,67/23216,0.00107662284851,0.013027136467,CCNT2; PRKCZ; PPM1A,5590/5494/905,3,4,0.0447761194029851,0.0028859407305306
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,2/38,38/23216,0.00587110860659,0.0296001725582,CCNT2; PPM1A,5494/905,2,4,0.0526315789473684,0.0016368022053756
WP2895,Differentiation of white and brown adipocyte,2/25,25/23216,0.00256831865884,0.0194229098575,PRDM16; ZNF423,23090/63976,2,1,0.08,0.0010768435561681
WP2369,Histone Modifications,2/66,66/23216,0.0169863291878,0.0454699462002,SETD3; SETD5,55209/84193,2,1,0.0303030303030303,0.0028428669882839
R-HSA-3214841,PKMTs methylate histone lysines,2/73,72/23216,0.0200124704591,0.0507145990287,PRDM16; SETD3,84193/63976,2,1,0.0273972602739726,0.0031013094417643
R-HSA-3214815,HDACs deacetylate histones,2/94,94/23216,0.0328310174673,0.0568612871039,HDAC10; RCOR1,23186/83933,2,5,0.0212765957446809,0.0040489317711922
